156 related articles for article (PubMed ID: 32729243)
1. Phenotypic variance in monozygotic twins with SCA3.
Zhao H; Yang L; Dong Y; Wu ZY
Mol Genet Genomic Med; 2020 Oct; 8(10):e1438. PubMed ID: 32729243
[TBL] [Abstract][Full Text] [Related]
2. Alteration of methylation status in the ATXN3 gene promoter region is linked to the SCA3/MJD.
Wang C; Peng H; Li J; Ding D; Chen Z; Long Z; Peng Y; Zhou X; Ye W; Li K; Xu Q; Ai S; Song C; Weng L; Qiu R; Xia K; Tang B; Jiang H
Neurobiol Aging; 2017 May; 53():192.e5-192.e10. PubMed ID: 28094059
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and genetic characteristics of homozygous spinocerebellar ataxia type 3.
Li QF; Cheng HL; Yang L; Ma Y; Zhao JJ; Dong Y; Wu ZY
Mol Genet Genomic Med; 2020 Sep; 8(9):e1314. PubMed ID: 32643267
[TBL] [Abstract][Full Text] [Related]
4. Variation in DNA Repair System Gene as an Additional Modifier of Age at Onset in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.
Mergener R; Furtado GV; de Mattos EP; Leotti VB; Jardim LB; Saraiva-Pereira ML
Neuromolecular Med; 2020 Mar; 22(1):133-138. PubMed ID: 31587151
[TBL] [Abstract][Full Text] [Related]
5. RAN Translation of the Expanded CAG Repeats in the SCA3 Disease Context.
Jazurek-Ciesiolka M; Ciesiolka A; Komur AA; Urbanek-Trzeciak MO; Krzyzosiak WJ; Fiszer A
J Mol Biol; 2020 Dec; 432(24):166699. PubMed ID: 33157084
[TBL] [Abstract][Full Text] [Related]
6. Spinocerebellar ataxia type 3/Machado-Joseph disease: segregation patterns and factors influencing instability of expanded CAG transmissions.
Souza GN; Kersting N; Krum-Santos AC; Santos AS; Furtado GV; Pacheco D; Gonçalves TA; Saute JA; Schuler-Faccini L; Mattos EP; Saraiva-Pereira ML; Jardim LB
Clin Genet; 2016 Aug; 90(2):134-40. PubMed ID: 26693702
[TBL] [Abstract][Full Text] [Related]
7. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds.
Tang B; Liu C; Shen L; Dai H; Pan Q; Jing L; Ouyang S; Xia J
Arch Neurol; 2000 Apr; 57(4):540-4. PubMed ID: 10768629
[TBL] [Abstract][Full Text] [Related]
8. Childhood-Onset Spinocerebellar Ataxia 3: Tongue Dystonia as an Early Manifestation.
Mitchell N; LaTouche GA; Nelson B; Figueroa KP; Walker RH; Sobering AK
Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31565539
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation age acceleration is associated with age of onset in Chinese spinocerebellar ataxia type 3 patients.
Li J; Shu A; Sun Y; Yang W; Tang X; Pu H; Peng Y; Hu X; Qing Y; Wang J; Wan C; Zhou M; Zhang M
Neurobiol Aging; 2022 May; 113():1-6. PubMed ID: 35247757
[TBL] [Abstract][Full Text] [Related]
10. Six cases of SCA3/MJD patients that mimic hereditary spastic paraplegia in clinic.
Wang YG; Du J; Wang JL; Chen J; Chen C; Luo YY; Xiao ZQ; Jiang H; Yan XX; Xia K; Pan Q; Tang BS; Shen L
J Neurol Sci; 2009 Oct; 285(1-2):121-4. PubMed ID: 19608203
[TBL] [Abstract][Full Text] [Related]
11. Effects of SCA1, MJD, and DPRLA triplet repeat polymorphisms on cognitive phenotypes in a normal population of adolescent twins.
Luciano M; Hine E; Wright MJ; Duffy DL; MacMillan J; Martin NG
Am J Med Genet B Neuropsychiatr Genet; 2007 Jan; 144B(1):95-100. PubMed ID: 16967484
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of PNKP by mutant ATXN3 triggers apoptosis by activating the DNA damage-response pathway in SCA3.
Gao R; Liu Y; Silva-Fernandes A; Fang X; Paulucci-Holthauzen A; Chatterjee A; Zhang HL; Matsuura T; Choudhary S; Ashizawa T; Koeppen AH; Maciel P; Hazra TK; Sarkar PS
PLoS Genet; 2015 Jan; 11(1):e1004834. PubMed ID: 25590633
[TBL] [Abstract][Full Text] [Related]
13. In vivo assessment of riluzole as a potential therapeutic drug for spinocerebellar ataxia type 3.
Schmidt J; Schmidt T; Golla M; Lehmann L; Weber JJ; Hübener-Schmid J; Riess O
J Neurochem; 2016 Jul; 138(1):150-62. PubMed ID: 26990650
[TBL] [Abstract][Full Text] [Related]
14. Clinical features and genetic diagnosis of hereditary spinocerebellar ataxia 3.
Wang Y; Yang X; Ma W; Li J; Zhang Q; Xia S; Wang H; Zhang C; Xu X; Zheng J
Mol Med Rep; 2016 Oct; 14(4):3731-4. PubMed ID: 27600091
[TBL] [Abstract][Full Text] [Related]
15. High Serum GFAP Levels in SCA3/MJD May Not Correlate with Disease Progression.
Shi Y; Wang C; Huang F; Chen Z; Sun Z; Wang J; Tang B; Ashizawa T; Klockgether T; Jiang H
Cerebellum; 2015 Dec; 14(6):677-81. PubMed ID: 25869927
[TBL] [Abstract][Full Text] [Related]
16. Generation of an induced pluripotent stem cell line from a patient with spinocerebellar ataxia type 3 (SCA3): HIHCNi002-A.
Hayer SN; Schelling Y; Huebener-Schmid J; Weber JJ; Hauser S; Schöls L
Stem Cell Res; 2018 Jul; 30():171-174. PubMed ID: 29936336
[TBL] [Abstract][Full Text] [Related]
17. Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein.
Ashraf NS; Sutton JR; Yang Y; Ranxhi B; Libohova K; Shaw ED; Barget AJ; Todi SV; Paulson HL; Costa MDC
Neurobiol Dis; 2020 Apr; 137():104697. PubMed ID: 31783119
[TBL] [Abstract][Full Text] [Related]
18. Homozygous spinocerebellar ataxia type 3 in China: a case report.
Chen Y; Li D; Wei M; Zhou M; Zhang L; Yu J; Qiu M; Jin Y; Lu X
J Int Med Res; 2021 Jun; 49(6):3000605211021370. PubMed ID: 34167352
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9-Targeted Deletion of Polyglutamine in Spinocerebellar Ataxia Type 3-Derived Induced Pluripotent Stem Cells.
Ouyang S; Xie Y; Xiong Z; Yang Y; Xian Y; Ou Z; Song B; Chen Y; Xie Y; Li H; Sun X
Stem Cells Dev; 2018 Jun; 27(11):756-770. PubMed ID: 29661116
[TBL] [Abstract][Full Text] [Related]
20. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.
Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M
Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
